Medical Doctor Program year 2023 Reported 2020–2023 Source: CMS Open Payments, 2026 publication

William Cox

Orthopaedic Surgery Ocoee, FL Medical Doctor

NPI 1457336505 CMS profile 338726

596 Ocoee Commerce Pkwy, Ocoee, FL 34761

Open in the dashboard

General payments

$475

9 records reported · program years 2020–2023

Research payments

$0

Paid to them · None reported · program years 2020–2023

Ownership & investment interest

$0

None reported

Through program year 2023, William Cox of Ocoee, FL is reported in the CMS Open Payments database as having received $475 across 9 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 21st percentile of Orthopaedic Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

4 rows
Year Kind Relative to this record's peak year Amount Records
2023 General $46 1
2022 General $217 2
2021 General $176 5
2020 General $36 1

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • William Cox
  • Orthopaedic Surgery median
  • Middle half of Orthopaedic Surgery
  • National median

In program year 2025, general payments to William Cox were reported at $0. Among 15,343 Orthopaedic Surgery profiles paid that year, the median was $563 and the middle half received between $147 and $2,717.

Show as a table
Year William Cox Orthopaedic Surgery median Middle half National median
2019 $0 $644 $140–$2,844 $163
2020 $36 $312 $75–$1,860 $114
2021 $176 $520 $117–$2,495 $132
2022 $217 $598 $128–$2,731 $149
2023 $46 $461 $128–$2,264 $160
2024 $0 $497 $134–$2,475 $164
2025 $0 $563 $147–$2,717 $169

Breakdown

Who paid General payments · program years 2020–2023
  1. Stryker Corporation $299 4 payments
  2. Zimmer Biomet Holdings, Inc. $127 2 payments
  3. OSSIO Inc. $19 1 payment
  4. DePuy Synthes Sales Inc. $19 1 payment
  5. Smith+Nephew, Inc. $11 1 payment

Every payment, record by record

What the payments were for General payments · program years 2020–2023
  1. Food and Beverage $475 9 payments
Products named General payments · program years 2020–2023
  1. MAKO Knees, Hips $263 3 payments
  2. Comp Primary Revision Stem $127 2 payments
  3. MAKO Knees, Hips $36 1 payment
  4. MONOVISC $19 1 payment
  5. ORTHOVISC $19 1 payment
  6. PICO 14 $11 1 payment

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 13 drugs

Part D claims

1,045

Median for Orthopedic Surgery: 203

Drug cost

$11,308

Median for Orthopedic Surgery: $1,433

Branded share of claims

2.2%

Median for Orthopedic Surgery: 11.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Celecoxib Generic 285 $6,211
Fentanyl Generic 12 $962
Meloxicam Generic 313 $888
Diclofenac Sodium Generic 49 $886
Tramadol Hcl Generic 162 $790
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 23 $441
Ibuprofen Generic 55 $312
Methocarbamol Generic 35 $207
Methylprednisolone Generic 21 $206
Amoxicillin Generic 48 $158

The 10 drugs with the highest cost, of 13 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 18,934 Part D prescribers listed as Orthopedic Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 44 billing codes

Paid by Medicare

$86,352

Of which drugs: $825

Medicare patients

335

Average age 75

Services billed

2,659

189 women, 146 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 72%
Ischemic heart disease 39%
Diabetes 36%
Chronic kidney disease 36%
Atrial fibrillation 21%
Depression 18%
Heart failure 16%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Injection, triamcinolone acetonide, not otherwise specified, 10 mg J3301 Office 151 1,145 $825

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

9 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Orthopaedic Surgery in Florida

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2023

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record